HIV and hepatitis C study in European adults
Part of Digestive system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections, Injuries & trauma, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be infected with HIV-1 (a specific type of HIV)
- Have a positive blood test for hepatitis C antibodies
- Be at least 16 years old
- Do not already be enrolled in the EuroSIDA study from an earlier group
- There must still be room for new participants (the target number must not be reached)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both HIV and hepatitis B over time to better understand how the infection responds after starting treatment. Your information (and sometimes stored blood samples) helps researchers track changes from the start of therapy to about 2 years later.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
This study follows people who have tested positive for HIV. It aims to better understand HIV over time, but you can only participate if you agree to join the study.
This study looks back at people with HIV to understand how often and why heart problems happen. It may help doctors better track heart risk and complications over time.
This study is looking for people in south-east Austria who have hepatitis B (HBV) or hepatitis C (HCV) that hasn't been fully treated or documented. It aims to find how many people also have hepatitis D (HDV) and are not yet aware of it.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.